Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 11 (Search time: 0.003 seconds).

  Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets (Journal article)

  Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative study (Journal article)

  Amphipathic alpha-helical peptide models of apolipoprotein A-I inhibit LDL oxidation and inactivation of PAF-acetyl-hydrolase in vitro (Journal article)

  Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3) (Journal article)

  Mapping the binding domains of the alpha(IIb) subunit - A study performed on the activated form of the platelet integrin alpha(IIb)beta(3) (Journal article)

  Conformational study of new amphipathic alpha-helical peptide models of apoA-I as potential atheroprotective agents (Journal article)

  Synthetic peptide-analogues of the GPIIb subunit inhibit fibrinogen binding to the GPIIb/IIIa receptor and platelet activation (Journal article)

  Antioxidant effects of alpha-helix apolipoprotein A-I peptide models in relation to their structure (Journal article)

  Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3) (Journal article)

  Apolipoprotein AI peptide models enhance the antioxidant effectiveness of high density lipoprotein subspecies HDL3c (Journal article)